Vaccitech plc American Depositary Shares

VACC: Vaccitech PLC is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious disease, cancer, and immune tolerance. Its therapeutic programs include VTP-300, in chronic hepatitis B viral (HBV) infection; VTP-200, in high-risk human papillomavirus (HPV); and VTP-850, in prostate cancer and among others. In addition, it also co-invented a COVID-19 vaccine candidate with the University of Oxford known as COVID-19 Vaccine AstraZeneca.